Vascular-targeted Therapy: Novel Approach to COPD Treatment?

Matthew Lammi, M.D.
Assistant Professor of Clinical Medicine LSU School of Medicine
Location: CSRB seminar room 563

For more information or program materials email Matthew Lammi, M.D. at mlammi@lsuhsc.edu

  • Explain the vascular hypothesis of COPD pathogenesis.
  • Understand the mechanistic rationale for an inhaled prostanoid treatment in COPD.
  • Synthesize pre-clinical and human data on iloprost use in COPD.


Accreditation: The Louisiana State University School of Medicine, New Orleans is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement: The Louisiana State University School of Medicine, New Orleans designates this live activity for a maximum 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.